Jazz Pharmaceuticals plc (JAZZ)

NASDAQ: JAZZ · Real-Time Price · USD

229.19

-2.85 (-1.23%)

At close: Jun 9, 2026, 4:00 PM EDT

226.00

-3.19 (-1.39%)

After-hours: Jun 9, 2026, 7:38 PM EDT

Jazz Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	4,439	4,268	4,069	3,834	3,659	3,094
Revenue Growth (YoY)	9.20%	4.88%	6.12%	4.78%	18.26%	30.91%
Cost of Revenue	532.78	503.3	445.71	435.58	540.52	440.76
Gross Profit	3,906	3,764	3,623	3,399	3,119	2,653
Selling, General & Admin	1,648	1,809	1,385	1,343	1,417	1,452
Depreciation & Amortization Expenses	672.51	654.66	627.31	608.28	599.17	525.77
Research & Development	798.08	782.74	884	849.66	590.45	505.75
Other Operating Expenses	1,071	947.86	10	19	577.8	-
Total Operating Expenses	4,189	4,195	2,907	2,820	3,184	2,483
Operating Income	-37.75	-430.24	716.63	578.58	-65.53	170.28
Interest Expense	-181.25	-195.05	-238.1	-289.44	-288.24	-278.77
Other Non-Operating Income (Expense)	-0.51	-2.57	-8.18	8.79	-19.01	-4.35
Total Non-Operating Income (Expense)	-181.76	-197.62	-246.28	-280.65	-307.26	-283.12
Pretax Income	-218.85	-627.86	470.35	297.93	-372.78	-112.84
Provision for Income Taxes	-248.53	-272.44	-91.43	-119.91	-158.65	216.12
Net Income	29.68	-355.42	561.78	417.84	-214.14	-328.95
Minority Interest in Earnings	0.19	0.73	1.66	3.01	9.92	0.71
Net Income to Common	29.49	-356.15	560.12	414.83	-224.06	-329.67
Net Income Growth	-93.88%	-	35.02%	-	-	-
Shares Outstanding (Basic)	61	61	62	63	63	60
Shares Outstanding (Diluted)	63	61	66	72	63	60
Shares Change (YoY)	-1.16%	-7.61%	-8.41%	15.23%	4.77%	5.62%
EPS (Basic)	0.46	-5.84	9.06	6.55	-3.58	-5.52
EPS (Diluted)	-0.02	-5.84	8.65	6.10	-3.58	-5.52
EPS Growth	-	-	41.80%	-	-	-
Free Cash Flow	1,270	1,297	1,358	1,068	1,243	750.87
Free Cash Flow Growth	-2.11%	-4.48%	27.13%	-14.07%	65.53%	-15.12%
Free Cash Flow Per Share	20.13	21.27	20.57	14.82	19.87	12.58
Gross Margin	88.00%	88.21%	89.05%	88.64%	85.23%	85.76%
Operating Margin	-0.85%	-10.08%	17.61%	15.09%	-1.79%	5.50%
Profit Margin	0.67%	-8.33%	13.81%	10.90%	-5.85%	-10.63%
FCF Margin	28.60%	30.39%	33.37%	27.86%	33.97%	24.27%
EBITDA	675.15	266.06	1,377	1,217	563.94	722.76
EBITDA Margin	15.21%	6.23%	33.83%	31.75%	15.41%	23.36%
EBIT	-37.75	-430.24	716.63	578.58	-65.53	170.28
EBIT Margin	-0.85%	-10.08%	17.61%	15.09%	-1.79%	5.50%
Effective Tax Rate	113.56%	43.39%	-19.44%	-40.25%	42.56%	-191.53%

SEC Filings: 10-K · 10-Q